We speculate that the obese/T2D individuals with higher systemic and local (broncho-pulmonary epithelial) expression of MCP-1 may be at a high risk and more prone to develop asthma and further studies will be required to verify this line of argument. This evidence concerns the gene CCL2 and type 2 diabetes mellitus.